Literature DB >> 23067903

Saphenous vein graft percutaneous coronary intervention via radial artery access: safe and effective with reduced hospital length of stay.

Shantu S Bundhoo1, Eleanor Earp, Taida Ivanauskiene, Vijay Kunadian, Phillip Freeman, Richard Edwards, Tim D Kinnaird, Azfar Zaman, Richard A Anderson.   

Abstract

BACKGROUND: Although percutaneous coronary intervention (PCI) via radial artery access confers many advantages over the femoral artery, PCI to saphenous vein grafts (SVG) is commonly performed via the femoral route. We compared outcomes in patients undergoing SVG PCI from the radial and femoral routes.
METHODS: We performed a retrospective analysis of patients who underwent SVG PCI between January 2006 and December 2010 in 2 large interventional centers in the United Kingdom. All radial and femoral operators selected for this analysis performed high-volume (>200 PCIs per year) procedures via either vascular route.
RESULTS: Of 305 patients (260 males) who underwent SVG PCI, 208 (68.2%) had the procedure completed from the femoral route and 97 (32.8%) radially. There was no difference between groups in fluoroscopy time (femoral vs radial 1095 vs 1125 seconds, P nonsgnificant), but radiation doses were greater (43.87 ± 2.83 Gy/cm(2) vs 56.92 ± 4.52 Gy/cm(2), P = .012) as was body mass index in the radial group (27.99 ± 0.33 vs 29.05 ± 0.42, P = .048). Three femoral access patients had vascular access complications, whereas the radial route group had none. There were no differences in no flow/slow flow (femoral 3.86% vs radial 2.54%, P nonsignificant). The mean length of hospital stay was significantly shorter in the radial access cohort (1.09 vs 2.09 days, P < .001). Three patients converted from radial to femoral artery, whereas one converted from femoral to radial after technical failure to complete the procedure.
CONCLUSION: Saphenous vein graft PCI can be safely and effectively performed via radial artery access with comparable fluoroscopy times but not radiation doses. Of clinical significance, use of the radial artery access was associated with decreased hospital stay and arterial complications. These data suggest that a routine radial approach for SVG PCI is feasible and could offer clinical and economic benefits.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23067903     DOI: 10.1016/j.ahj.2012.07.029

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

1.  Saphenous vein graft interventions.

Authors:  Emmanouil S Brilakis; Michael Lee; Julinda Mehilli; Konstantinos Marmagkiolis; Josep Rodes-Cabau; Rajesh Sachdeva; Anna Kotsia; George Christopoulos; Bavana V Rangan; Atif Mohammed; Subhash Banerjee
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-05

2.  A comparison of the transradial and transfemoral approaches for the angiography and intervention in patients with a history of coronary artery bypass surgery: in-hospital and 1-year follow-up results.

Authors:  Pei-Yuan He; Yue-Jin Yang; Shu-Bin Qiao; Bo Xu; Min Yao; Yong-Jian Wu; Jin-Qing Yuan; Jue Chen; Hai-Bo Liu; Jun Dai; Xin-Ran Tang; Yang Wang; Wei Li; Run-Lin Gao
Journal:  Chin Med J (Engl)       Date:  2015-03-20       Impact factor: 2.628

3.  Ultrasonic Technology Improves Radial Artery Puncture and Cannulation in Intensive Care Unit (ICU) Shock Patients.

Authors:  Xiuyan Li; Guizhen Fang; Danhua Yang; Lanfang Wang; Chunmei Zheng; Longjuan Ruan; Lingcong Wang
Journal:  Med Sci Monit       Date:  2016-07-11

4.  One-year outcomes of percutaneous coronary intervention in native coronary arteries versus saphenous vein grafts in patients with prior coronary artery bypass graft surgery.

Authors:  Amr Abdelrahman; Maciej Dębski; Ranjit More; Hesham K Abdelaziz; Tawfiqur Choudhury; Jonas Eichhofer; Billal Patel
Journal:  Cardiol J       Date:  2020-10-01       Impact factor: 3.487

5.  Transradial Versus Transfemoral Approach for Coronary Angiography in Females with Prior Bypass Surgery.

Authors:  Ahmed Amro; Kanaan Mansoor; Mohammad Amro; Hisham Hirzallah; Amal Sobeih; Damir Kusmic; Ziad Abuhelwa; Majd Kanbour; Adee Elhamdani; Obadah Aqtash; Mehiar Elhamdani
Journal:  Cureus       Date:  2020-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.